Strata Skin Sciences Pre-Tax Income 2010-2024 | SSKN
Strata Skin Sciences pre-tax income from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
| Strata Skin Sciences Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2023 | $-11 |
| 2022 | $-5 |
| 2021 | $-3 |
| 2020 | $-4 |
| 2019 | $-4 |
| 2018 | $-4 |
| 2017 | $-21 |
| 2016 | $-3 |
| 2015 | $-25 |
| 2014 | $-14 |
| 2013 | $-26 |
| 2012 | $-23 |
| 2011 | $-20 |
| 2010 | $-20 |
| 2009 | $-18 |
| Strata Skin Sciences Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-2 |
| 2024-06-30 | $-0 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-4 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-3 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $-0 |
| 2022-09-30 | $-1 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-1 |
| 2021-09-30 | $-1 |
| 2021-06-30 | $1 |
| 2021-03-31 | $-2 |
| 2020-12-31 | $-0 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-1 |
| 2019-12-31 | $-1 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $0 |
| 2018-09-30 | $-1 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-14 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $-2 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-1 |
| 2016-06-30 | $1 |
| 2016-03-31 | $-1 |
| 2015-12-31 | $-0 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-8 |
| 2015-03-31 | $-7 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-2 |
| 2014-06-30 | $1 |
| 2014-03-31 | $-8 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-7 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $-7 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-5 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-6 |
| 2011-12-31 | $-5 |
| 2011-09-30 | $-6 |
| 2011-06-30 | $-5 |
| 2011-03-31 | $-5 |
| 2010-12-31 | $-5 |
| 2010-09-30 | $-5 |
| 2010-06-30 | $-5 |
| 2010-03-31 | $-5 |
| 2009-12-31 | $-6 |
| 2009-09-30 | $-5 |
| 2009-06-30 | $-4 |
| 2009-03-31 | $-4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.013B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.226B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.656B | 176.38 |
| Hims & Hers Health (HIMS) | United States | $5.534B | 140.72 |
| Enovis (ENOV) | United States | $2.608B | 17.68 |
| Privia Health (PRVA) | United States | $2.587B | 215.60 |
| IRhythm Technologies (IRTC) | United States | $2.316B | 0.00 |
| Azenta (AZTA) | United States | $2.209B | 110.15 |
| Omnicell (OMCL) | United States | $2.116B | 69.23 |
| 10x Genomics (TXG) | United States | $1.732B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.689B | 0.00 |
| Schrodinger (SDGR) | United States | $1.518B | 0.00 |
| Phreesia (PHR) | United States | $1.148B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.690B | 0.00 |
| Standard BioTools (LAB) | United States | $0.596B | 0.00 |
| Talkspace (TALK) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.547B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.505B | 87.40 |
| Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
| Pulmonx (LUNG) | United States | $0.268B | 0.00 |
| TruBridge (TBRG) | United States | $0.247B | 71.91 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| American Well (AMWL) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.074B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Zepp Health (ZEPP) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |